Triveni Bio Inc., a biotech company specializing in novel antibody treatments for immunological and inflammatory disorders, has successfully secured $115 million in Series B funding. The funding round was led by Goldman Sachs Alternatives, with significant participation from new investors Fidelity Management & Research Company and Deep Track Capital, along with existing investors Atlas Venture,…
FIDO AI Ltd, a software company specializing in AIled nonrevenue water reduction and water data insights, has successfully raised Series B funding to support its growth and scale in the global water management sector. The funding will be used to further develop FIDOs technology and expand its reach in water resilience and stewardship across various…
Aktis Oncology, a clinicalstage biotechnology company specializing in targeted alpha radiopharmaceuticals for solid tumors, has successfully closed an oversubscribed and upsized $175 million Series B financing. The funding will be utilized to advance the companys differentiated radiopharmaceutical pipeline, particularly their firstinclass Nectin4targeted miniprotein radioconjugate. Leading the financing round was RA Capital Management, coled by RTW…
Observe, Inc., a leading SaaS observability company, has unveiled Project Voyager, featuring an AI Investigator, OpenTelemetryNative APM, and Snowflake Observability to enhance troubleshooting capabilities. The funding round of $145 million in Series B was led by Evolution Equity Partners and Madrona Ventures. Madrona Managing Director Soma Somasegar joins Observes board of directors as a result…
Mendaera, Inc., a Silicon Valleybased healthcare technology company, has announced the completion of a $73 million Series B funding round. The funding will be utilized to further develop Mendaeras handheld robotic interventional platform, which integrates robotics, AI, realtime imaging, and virtual connectivity. The company aims to scale robotics and AI across mainstream medical procedures, particularly…
Helaina, a biotechnology company founded in 2019 by food scientist Laura Katz, focuses on transforming nutrition with human equivalent bioactive proteins. The company has raised a total of $83 million in equity funding, with the recent Series B round bringing in $45 million. The funding will be used to scale the availability of effera™ Human…
Luminance, a pioneer in LegalGrade™ AI, has recently announced its expansion into Dallas, Texas, to cater to the growing demand from U.S. customers. The company, founded by AI experts from the University of Cambridge, has experienced significant growth, with over onethird of its revenue now coming from the U.S. market. Following a successful funding round…
Vicebio Ltd, a biopharmaceutical company focusing on novel vaccines against respiratory viral infections, has announced a successful $100 million Series B financing round. The funding will support and accelerate the development of nextgeneration multivalent respiratory virus vaccines using their proprietary Molecular Clamp technology. This technology stabilizes viral glycoproteins in a highly immunogenic prefusion conformation, essential…
point.me is a points and travel reward search platform founded in 2022 that simplifies credit card and airline loyalty reward programs for consumers. The company has experienced significant growth through partnerships with American Express and Bilt Rewards, leading to recognition as a Most Innovative Company by Fast Company in 2024. The Series B funding of…
PictorLabs, a software company based in Los Angeles and spun off from the UCLA Colleges of Engineering and Medicine, is transforming histopathology with AIpowered virtual staining technology. Their innovative solution eliminates the need for toxic reagents and reduces turnaround times significantly, delivering digitally stained slides in minutes. The $30 million Series B funding round led…